Seroprotection rate for varicella was defined as the proportion of subjects who were seronegative at baseline and whose postvaccination titer was ≥5 units/mL detected by the glycoprotein antigen-based enzyme-linked immunosorbent assay. The gene discussed is ART4; the disease is chickenpox.